The United Laboratories International Holdings Limited
ULIHF
$1.64
-$0.1543-8.60%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -17.24% | -16.57% | 12.35% | 10.65% | 46.54% |
| Total Depreciation and Amortization | 18.94% | 19.89% | -2.54% | -4.02% | 0.23% |
| Total Amortization of Deferred Charges | 13.36% | 14.27% | -- | -- | -12.24% |
| Total Other Non-Cash Items | -1,016.70% | -1,024.03% | 39.22% | 37.11% | -27.01% |
| Change in Net Operating Assets | 129.21% | 129.45% | 95.38% | 95.45% | -480.02% |
| Cash from Operations | 9.40% | 10.28% | 49.14% | 46.88% | -10.85% |
| Capital Expenditure | -16.78% | -17.72% | -60.41% | -57.98% | -71.66% |
| Sale of Property, Plant, and Equipment | 270.96% | 273.82% | -27.49% | -28.61% | -71.58% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 25.67% | 25.08% | 184.91% | 180.60% | -2,268.61% |
| Cash from Investing | -2.85% | -3.67% | -32.80% | -30.79% | -146.44% |
| Total Debt Issued | 44.75% | 44.75% | -14.02% | -14.02% | -61.73% |
| Total Debt Repaid | 38.47% | 38.47% | 93.62% | 93.62% | 62.36% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -69.86% | -71.22% | -- | -- | -96.77% |
| Other Financing Activities | -87.01% | -87.01% | 215.14% | 215.14% | -130.40% |
| Cash from Financing | 31.59% | 31.04% | 215.25% | 213.50% | -175.25% |
| Foreign Exchange rate Adjustments | 43.94% | 43.48% | -8.45% | -9.86% | -157.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 53.23% | 52.86% | 125,146.60% | 123,302.94% | -167.39% |